These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 32799685)

  • 1. Novel Lung Tropic Adeno-Associated Virus Capsids for Therapeutic Gene Delivery.
    Carneiro A; Lee H; Lin L; van Haasteren J; Schaffer DV
    Hum Gene Ther; 2020 Sep; 31(17-18):996-1009. PubMed ID: 32799685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells.
    White AF; Mazur M; Sorscher EJ; Zinn KR; Ponnazhagan S
    Hum Gene Ther; 2008 Dec; 19(12):1407-14. PubMed ID: 18778196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium.
    Li W; Zhang L; Johnson JS; Zhijian W; Grieger JC; Ping-Jie X; Drouin LM; Agbandje-McKenna M; Pickles RJ; Samulski RJ
    Mol Ther; 2009 Dec; 17(12):2067-77. PubMed ID: 19603002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
    Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
    Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy.
    Guggino WB; Cebotaru L
    Hum Gene Ther; 2020 May; 31(9-10):538-541. PubMed ID: 32283956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments.
    Guggino WB; Cebotaru L
    Expert Opin Biol Ther; 2017 Oct; 17(10):1265-1273. PubMed ID: 28657358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: comparison with adenovirus vectors.
    Teramoto S; Bartlett JS; McCarty D; Xiao X; Samulski RJ; Boucher RC
    J Virol; 1998 Nov; 72(11):8904-12. PubMed ID: 9765435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy in cystic fibrosis.
    Flotte TR; Laube BL
    Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transduction of Surface and Basal Cells in Rhesus Macaque Lung Following Repeat Dosing with AAV1CFTR.
    Guggino WB; Yanda MK; Cebotaru CV; Cebotaru L
    Hum Gene Ther; 2020 Sep; 31(17-18):1010-1023. PubMed ID: 32862701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered Capsids for Efficient Gene Delivery to the Retina and Cornea.
    Frederick A; Sullivan J; Liu L; Adamowicz M; Lukason M; Raymer J; Luo Z; Jin X; Rao KN; O'Riordan C
    Hum Gene Ther; 2020 Jul; 31(13-14):756-774. PubMed ID: 32578442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-Associated Virus-Based Gene Therapy for Lifelong Correction of Genetic Disease.
    Brommel CM; Cooney AL; Sinn PL
    Hum Gene Ther; 2020 Sep; 31(17-18):985-995. PubMed ID: 32718227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Directions in Pulmonary Gene Therapy.
    Vu A; McCray PB
    Hum Gene Ther; 2020 Sep; 31(17-18):921-939. PubMed ID: 32814451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy.
    Flotte TR
    Curr Opin Mol Ther; 2001 Oct; 3(5):497-502. PubMed ID: 11699895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors.
    Halbert CL; Miller AD; McNamara S; Emerson J; Gibson RL; Ramsey B; Aitken ML
    Hum Gene Ther; 2006 Apr; 17(4):440-7. PubMed ID: 16610931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.
    Conrad CK; Allen SS; Afione SA; Reynolds TC; Beck SE; Fee-Maki M; Barrazza-Ortiz X; Adams R; Askin FB; Carter BJ; Guggino WB; Flotte TR
    Gene Ther; 1996 Aug; 3(8):658-68. PubMed ID: 8854091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis: a look into the future of prenatal screening and therapy.
    Nishida K; Smith Z; Rana D; Palmer J; Gallicano GI
    Birth Defects Res C Embryo Today; 2015 Mar; 105(1):73-80. PubMed ID: 25820246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing.
    de Alencastro G; Pekrun K; Valdmanis P; Tiffany M; Xu J; Kay MA
    Hum Gene Ther; 2020 May; 31(9-10):553-564. PubMed ID: 32024384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.
    Tang Y; Yan Z; Engelhardt JF
    Hum Gene Ther; 2020 May; 31(9-10):524-537. PubMed ID: 32138545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Modification of the AAV5 Capsid with Lysine Residues Results in a Lung-Tropic Liver-Detargeted Gene Transfer Vector.
    Stiles KM; Frenk EZ; Kaminsky SM; Crystal RG
    Hum Gene Ther; 2022 Feb; 33(3-4):148-154. PubMed ID: 35018834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms.
    Chen Q; Njenga R; Leuchs B; Chiocca S; Kleinschmidt J; Müller M
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.